Advertisement: Excalibur Healthcare mid banner
Advertisement: Bar Ellison mid banner property
Advertisement: EBCam mid banner
Mid banner advertisement: BDO
Advertisement: RSM mid banner
Advertisement: SATAVIA mid banner
Advertisement: Wild Knight Vodka
Advertisement: HCR Hewitsons mid banner
Advertisement: Mogrify mid banner
Barr Ellison Solicitors – commercial property
Advertisement: CJBS mid banner
Cambridgeand mid banner advertisement
Advertisement: Cambridge Network mid banner
Advertisement: Simpsons Creative
Advertisement: TTP
Advertisement: partnersand mid banner
Advertisement: Kao Data Centre mid banner
Advertisement: S-Tech mid banner 3
ARM Innovation Hub
2 December, 2010 - 23:57 By Staff Reporter

Selcia and Gilead Sciences extend liver collaboration

Selcia Limited, an Essex-based contract research organisation, has announced a new drug discovery collaboration agreement with Gilead Sciences, Inc. of California.

It builds on an established partnership following significant progress made to date. Selcia’s chemists and biologists will continue to provide integrated drug discovery services to support Gilead’s liver disease research programmes.

Dr William Lee, senior vice-president for research at Gilead Sciences, said: “This is a very important therapeutic area for Gilead. Scientists from both companies have interacted well together and have made successful progress against some difficult targets. “We are looking forward to the collaboration delivering candidates for clinical studies in the foreseeable future.”Selcia MD, Dr Hans Fliri added: “We are delighted to build on our strong collaborative relationship with Gilead in this challenging research area and important therapeutic indication. “This represents a significant step forward in the development of Selcia’s discovery services and further cements our position as a strategic and trusted partner for integrated drug discovery.”Selcia is a privately held CRO with two operating divisions, Selcia Discovery and Selcia Radiolabelling, operating from a modern facility in Ongar.

Add new comment

Newsletter Subscription

Stay informed of the latest news and features